Deutsche Bank’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$170K Buy
10,020
+9,714
+3,175% +$165K ﹤0.01% 3067
2025
Q4
$5.74K Sell
306
-10,744
-97% -$162K ﹤0.01% 3561
2025
Q3
$141K Hold
11,050
﹤0.01% 3219
2025
Q2
$186K Sell
11,050
-3,793
-26% -$51.2K ﹤0.01% 3008
2025
Q1
$190K Sell
14,843
-3,588
-19% -$57.6K ﹤0.01% 2972
2024
Q4
$325K Buy
18,431
+5,048
+38% +$95.7K ﹤0.01% 2863
2024
Q3
$306K Buy
13,383
+4,711
+54% +$106K ﹤0.01% 2713
2024
Q2
$199K Sell
8,672
-463
-5% -$14.3K ﹤0.01% 2806
2024
Q1
$362K Sell
9,135
-103
-1% -$4.07K ﹤0.01% 2505
2023
Q4
$365K Sell
9,238
-164
-2% -$6.87K ﹤0.01% 2543
2023
Q3
$417K Buy
9,402
+1,025
+12% +$44.7K ﹤0.01% 2290
2023
Q2
$364K Sell
8,377
-2,705
-24% -$119K ﹤0.01% 2535
2023
Q1
$482K Buy
11,082
+2,325
+27% +$103K ﹤0.01% 2520
2022
Q4
$327K Buy
8,757
+1,917
+28% +$74.2K ﹤0.01% 2691
2022
Q3
$273K Sell
6,840
-2,775
-29% -$103K ﹤0.01% 2752
2022
Q2
$369K Sell
9,615
-180
-2% -$6.51K ﹤0.01% 2779
2022
Q1
$388K Sell
9,795
-1,117
-10% -$43.7K ﹤0.01% 2902
2021
Q4
$454K Buy
10,912
+248
+2% +$10.8K ﹤0.01% 2907
2021
Q3
$449K Buy
10,664
+148
+1% +$7.45K ﹤0.01% 3113
2021
Q2
$482K Sell
10,516
-274
-3% -$13K ﹤0.01% 3246
2021
Q1
$506K Sell
10,790
-825
-7% -$40.1K ﹤0.01% 3094
2020
Q4
$496K Buy
11,615
+2,603
+29% +$134K ﹤0.01% 2906
2020
Q3
$443K Buy
9,012
+544
+6% +$30.1K ﹤0.01% 2710
2020
Q2
$493K Buy
8,468
+4,111
+94% +$217K ﹤0.01% 2653
2020
Q1
$198K Sell
4,357
-229
-5% -$13.8K ﹤0.01% 2948
2019
Q4
$301K Buy
4,586
+512
+13% +$31.3K ﹤0.01% 2997
2019
Q3
$233K Sell
4,074
-9,811
-71% -$608K ﹤0.01% 3100
2019
Q2
$797K Sell
13,885
-7,164
-34% -$331K ﹤0.01% 2994
2019
Q1
$810K Sell
21,049
-1,155
-5% -$45.2K ﹤0.01% 3135
2018
Q4
$844K Sell
22,204
-13,946
-39% -$536K ﹤0.01% 2999
2018
Q3
$1.4M Buy
36,150
+8,129
+29% +$308K ﹤0.01% 3089
2018
Q2
$1.05M Sell
28,021
-1,576
-5% -$54.9K ﹤0.01% 3389
2018
Q1
$862K Buy
29,597
+8,283
+39% +$278K ﹤0.01% 3402
2017
Q4
$793K Buy
21,314
+11,787
+124% +$418K ﹤0.01% 3354
2017
Q3
$357K Sell
9,527
-1,256
-12% -$39.5K ﹤0.01% 3588
2017
Q2
$289K Sell
10,783
-718
-6% -$17.6K ﹤0.01% 3735
2017
Q1
$225K Sell
11,501
-3,251
-22% -$60.1K ﹤0.01% 3529
2016
Q4
$279K Buy
14,752
+3,752
+34% +$61.9K ﹤0.01% 3495
2016
Q3
$178K Sell
11,000
-4,976
-31% -$78.1K ﹤0.01% 3709
2016
Q2
$217K Buy
15,976
+14,538
+1,011% +$205K ﹤0.01% 3734
2016
Q1
$22K Sell
1,438
-982
-41% -$14.4K ﹤0.01% 4610
2015
Q4
$37K Sell
2,420
-287
-11% -$4.36K ﹤0.01% 4538
2015
Q3
$32K Sell
2,707
-338
-11% -$4.49K ﹤0.01% 4618
2015
Q2
$42K Buy
3,045
+2,219
+269% +$31.4K ﹤0.01% 4669
2015
Q1
$11K Sell
826
-14
-2% -$198 ﹤0.01% 4787
2014
Q4
$11K Buy
840
+738
+724% +$10.8K ﹤0.01% 5692
2014
Q3
$1K Sell
102
-981
-91% -$13.5K ﹤0.01% 5769
2014
Q2
$15K Sell
1,083
-3,186
-75% -$47.9K ﹤0.01% 5401
2014
Q1
$70K Buy
4,269
+2,294
+116% +$38.4K ﹤0.01% 4393
2013
Q4
$37K Sell
1,975
-9,739
-83% -$171K ﹤0.01% 4476
2013
Q3
$220K Buy
11,714
+5,809
+98% +$99.8K ﹤0.01% 4063
2013
Q2
$105K Buy
+5,905
New +$94.3K ﹤0.01% 4195

Other funds holding NRC

Deutsche Bank's NRC Position: Q1 2026 in Review

Deutsche Bank increased its NRC Health Common Stock (NRC) stake by 3,175% in Q1 2026, buying an estimated $165K and bringing the position to 10,020 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #3067.

Deutsche Bank first reported a position in NRC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.4M in Q3 2018. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Deutsche Bank held 10,020 shares of NRC Health Common Stock worth $170K as of Q1 2026.
  • Deutsche Bank bought 9,714 NRC Health Common Stock shares in Q1 2026, an estimated $165K.
  • NRC Health Common Stock made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3067 holding.
  • Deutsche Bank first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's NRC Health Common Stock position peaked at $1.4M in Q3 2018.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.